GAL1704

GAL1704 is an investigational product evaluated for **cheek augmentation** and the correction of **midface volume deficiencies**.[2][4][10] Clinical trials are designed to test its safety and efficacy as a facial filler or volumizer, with a head-to-head comparison to active control treatments, commonly in the same category of biodegradable tissue augmentation agents. The developer, Galderma R&D, is a global dermatology-focused company specializing in innovative skin health therapies. Mechanism of action, active ingredient, and specific compound information are not disclosed in trial registries or public sources, but trial exclusion criteria mention prior use of "HA based or collagen based biodegradable tissue augmentation therapy," suggesting GAL1704 is likely a **biodegradable tissue filler** in a similar class (e.g., hyaluronic acid-based or collagen-based dermal filler), though the exact composition is not publicly revealed.[4]

Brand names

GAL1704GAL-1704GAL 1704

Other names

GAL1704GAL-1704GAL 1704